Bright Minds Biosciences (DRUG) Change in Receivables (2021 - 2026)
Bright Minds Biosciences (DRUG) posted Change in Receivables of $79229.7 for Q1 2026, up 287.13% on a QoQ basis from -$42340.4 in Q4 2025, and up 343.19% year-over-year from $17877.2 in Q1 2025.
Bright Minds Biosciences (DRUG) Change in Receivables (2021 - 2026) Analysis & Trends
Bright Minds Biosciences' Change in Receivables history runs 6 years deep, the most recent figure standing at $79229.7 for Q1 2026.
- Quarterly Change in Receivables rose 343.19% year-over-year to $79229.7 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$106493.1 (down 394.82% YoY) and the FY2025 annual result came in at -$147618.1, changed N/A from the prior year.
- Change in Receivables was $79229.7 for Q1 2026 at Bright Minds Biosciences, up from -$42340.4 in the prior quarter.
- Across five years, Change in Receivables topped out at $87821.1 in Q2 2022 and bottomed at -$100427.5 in Q3 2025.
- A 5-year average of -$4650.4 and a median of -$4048.3 in 2024 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2024 — Change in Receivables surged 399.7% — and 2025, when it plunged 961.05%.
- Bright Minds Biosciences' Change in Receivables stood at $40697.7 in 2022, then plunged by 85.45% to $5919.6 in 2023, then jumped by 399.7% to $29580.3 in 2024, then sank by 243.14% to -$42340.4 in 2025, then surged by 287.13% to $79229.7 in 2026.
- Business Quant data shows DRUG's Change in Receivables at $79229.7 in Q1 2026, -$42340.4 in Q4 2025, and -$100427.5 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 75.30 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.84 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bright Minds Biosciences | 498.53 Mn | 498.53 Mn | - | 79,229.66 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79,229.66 |
| Mar 31, 2026 | 79,229.66 |
| Dec 31, 2025 | -42,340.36 |
| Dec 31, 2025 | -42,340.36 |
| Sep 30, 2025 | -100,427.50 |
| Sep 30, 2025 | -100,427.50 |
| Jun 30, 2025 | -42,954.88 |
| Jun 30, 2025 | -42,954.88 |
| Mar 31, 2025 | -32,579.45 |
| Mar 31, 2025 | -32,579.45 |
| Dec 31, 2024 | 29,580.32 |
| Dec 31, 2024 | 29,580.32 |
| Sep 30, 2024 | -14,474.14 |
| Sep 30, 2024 | -14,474.14 |
| Jun 30, 2024 | -4,048.33 |
| Jun 30, 2024 | -4,048.33 |
| Mar 31, 2024 | 12,781.42 |
| Mar 31, 2024 | 12,781.42 |
| Dec 31, 2023 | 5,919.62 |
| Dec 31, 2023 | 5,919.62 |